Overview
Food Effect Study With BMS-955176
Status:
Completed
Completed
Trial end date:
2016-08-15
2016-08-15
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Bristol-Myers Squibb
ViiV HealthcareCollaborator:
GlaxoSmithKlineTreatments:
BMS-955176
Criteria
Inclusion Criteria:- Healthy subjects as determined by no clinically significant deviation from normal in
medical history, physical examinations, vital sign measurements, 12-lead ECG
measurements, and clinical laboratory test results
- Body mass index (BMI) of 18.0 to 32.0 kg/m2, inclusive. BMI = Weight (kg)/[Height
(m)]2
- Men and women, ages 18 to 50 years, inclusive
- Women must not be of childbearing potential, must not be breastfeeding
Exclusion Criteria:
- Any significant acute or chronic medical illness
- History of cardiac disease or clinically significant cardiac arrhythmias
- Current or recent (within 3 months of study drug administration) gastrointestinal
disease
- Any major surgery within 4 weeks of study drug administration
- Any gastrointestinal surgery (including cholecystectomy) that could impact upon the
absorption of study drug